Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction

Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction

Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superficial bladder cancer. Intravesical instillation of liposomal botulinum toxin has recently shown promise in the treatment of overactive bladder and interstitial cystitis/bladder pain syndrome, and studi...

Full description

Bibliographic Details
Main Authors:	Joseph J. Janicki, Michael B. Chancellor, Jonathan Kaufman, Michele A. Gruber, David D. Chancellor
Format:	Article
Language:	English
Published:	MDPI AG 2016-03-01
Series:	Toxins
Subjects:	liposome bladder interstitial cystitis overactive bladder botulinum toxin
Online Access:	http://www.mdpi.com/2072-6651/8/3/81

Similar Items

Role of liposome in treatment of overactive bladder and interstitial cystitis
by: Shih-Ya Hung, et al.
Published: (2015-03-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
by: Jia-Fong Jhang, et al.
Published: (2016-04-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)

Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome
by: Wei-Ching Lee, et al.
Published: (2011-10-01)

Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies
by: Ting-Chun Yeh, et al.
Published: (2020-02-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Applications of electromotive drug administration in urology
by: Safiya Hashemi, et al.
Published: (2020-01-01)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
by: Chung-Cheng Wang, et al.
Published: (2020-03-01)

Effect of Low-Dose Triple Therapy Using Gabapentin, Amitriptyline, and a Nonsteroidal Anti-Inflammatory Drug for Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome
by: Whi-An Kwon, et al.
Published: (2013-06-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
by: Bin Chiu, et al.
Published: (2016-07-01)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
by: Luke Grundy, et al.
Published: (2018-12-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?
by: Shannon HK Kim, et al.
Published: (2016-03-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Possible Pathomechanisms and Practical Issues
by: Jia-Fong Jhang
Published: (2019-11-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder
by: Po-Yen Chen, et al.
Published: (2020-01-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

BOTULINUM TOXIN A FOR THE MANAGEMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
by: V. L. Medvedev, et al.
Published: (2017-10-01)

Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?
Published: (2023)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

The innovative therapeutic application of botulinum toxin type A in urology patients
by: Chrysoula Belai, et al.
Published: (2016-06-01)

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
by: Shu-Yu Wu, et al.
Published: (2021-06-01)

Proteomic analysis of bladder biopsies from interstitial cystitis/bladder pain syndrome patients with and without Hunner’s lesions reveals differences in expression of inflammatory and structural proteins
by: Elijah P. Ward, et al.
Published: (2020-11-01)

A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
by: Yi-Huei Chang, et al.
Published: (2020-06-01)

Predictors of Nerve Stimulator Success in Patients With Overactive Bladder
by: Kristian D. Stensland, et al.
Published: (2018-09-01)

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?
by: Mahtab Zargham, et al.
Published: (2017-01-01)

Botulinum toxin injection: a review of injection principles and protocols
by: David E. Rapp, et al.
Published: (2007-04-01)

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome
by: Hsiu-Jen Wang, et al.
Published: (2019-11-01)

Cannot write session to /tmp/vufind_sessions/sess_ke7t5bf43g095ql5jeqmsugqjn